Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Experts recommend universal screening of newborns for congenital adrenal hyperplasia

September 7, 2010 By EurekAlert

Chevy Chase, MD—Today, The Endocrine Society released a
new clinical practice guideline on the diagnosis and treatment of
congenital adrenal hyperplasia (CAH). The guideline features a
series of evidence-based clinical recommendations developed by an
expert task force.

The guideline, published in the September 2010 issue of the
Journal of Clinical Endocrinology & Metabolism
(JCEM), a publication of The Endocrine Society, is endorsed
by the American Academy of Pediatrics, Pediatric Endocrine Society,
the European Society for Paediatric Endocrinology, the European
Society of Endocrinology, the Society for Pediatric Urology, the
Androgen Excess and PCOS Society, and the CARES Foundation.

CAH is a genetic disorder of the adrenal glands that affects
about one in 10,000 to 20,000 newborns, both male and female. The
adrenal glands make the steroid hormones cortisol, aldosterone and
androgens. In individuals with CAH, the adrenal glands produce an
imbalance of these hormones which can result in ambiguous genitalia
in newborn females, infertility and the development of masculine
features such as development of pubic hair, rapid growth in both
girls and boys before the expected age of puberty.

“If CAH is not recognized and treated, both girls and boys
undergo rapid postnatal growth and early sexual development or, in
more severe cases, neonatal salt loss and death,” said Phyllis
Speiser, MD, of Cohen Children’s Medical Center of New York and
Hofstra University School of Medicine, and chair of the task force
that developed the guideline. “We recommend that every newborn be
screened for CAH and that positive results be followed up with
confirmatory tests.”

Other recommendations from the guideline include:

  • Prenatal treatment of CAH should continue to be regarded as
    experimental. Such therapies should be pursued through protocols
    approved by Institutional Review Boards at centers capable of
    collecting outcomes data on a large number of patients so that
    risks and benefits of this treatment can be defined more
    precisely;
  • Diagnosis should rest on clinical and hormone data while
    genotyping should be reserved for equivocal cases and genetic
    counseling;
  • Regarding treatment, glucocorticoid dosage should be minimized
    to avoid iatrogenic Cushing’s Syndrome. Mineralcorticoids and, in
    infants, supplemental sodium are recommended in classic CAH
    patients;
  • Clinicians should avoid the routine use of experimental
    therapies to promote growth and delay puberty, and patients should
    avoid adrenalectomy;
  • Early single-stage genital repair should be considered for
    severely virilized girls and should be performed only by surgeons
    experienced in this type of procedure;
  • Clinicians should consider patients’ quality of life,
    consulting mental health professionals as appropriate;
  • At the transition to adulthood, clinicians should monitor for
    potential complications of CAH; and
  • Clinicians should exercise judicious use of medication during
    pregnancy and in symptomatic patients with nonclassic CAH.

“People with classic CAH should have a team of health care
providers, including specialists in pediatric endocrinology,
pediatric urologic surgery (for girls), psychology and genetics,”
said Speiser. “Other than having to take daily medication, people
with classic CAH can have a normal life.”

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech